Legal & General Group PLC Talis Biomedical Corp Transaction History

Legal & General Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.81 - $1.44 $869 - $1,546	-1,074 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$9.62 - $14.56 $2,462 - $3,727	-256 Reduced 19.25%	1,074 $12,000
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $14,895 - $36,974	1,330 New	1,330 $17,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.6M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.